It acts as the chiral amine component, typically conjugated with a pyrimidine-cyclohexanecarboxamide moiety to form the final API. (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is a key chiral intermediate employed to synthesize Pralsetinib, a RET selective inhibitor used for cancer treatment.
(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine
| API Name | Pralsetinib |
|---|---|
| CAS No | 1980023-96-8 |
| Molecular Formula | C10H11FN4 |
| Molecular Weight | 206.22 g/mol |
| Synonyms | (1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethanamine |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It acts as the chiral amine component, typically conjugated with a pyrimidine-cyclohexanecarboxamide moiety to form the final API. (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is a key chiral intermediate employed to synthesize Pralsetinib, a RET selective inhibitor used for cancer treatment.
The CAS number of (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is 1980023-96-8.
The molecular formula of (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is C10H11FN4.
The listed molecular weight of (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is 206.22 g/mol.
(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is listed as being used in connection with the following API: Pralsetinib.
The listed synonym or IUPAC name for (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine is (1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethanamine.